Endothelial expression of the receptor for advanced glycation end products in experimental diabetes

Muñoz, Nelson; Mosquera, Jesús; Pedreañez, Adriana.
Int. j. med. surg. sci. (Print) ; 9(2): 1-10, June 2022. ilus
Artículo en Español | LILACS | ID: biblio-1512565

Documentos relacionados

  1. Development of Receptor for Advanced Glycation End Products (RAGE) ligands through target directed dynamic combinatorial chemistry: a novel class of possible antagonists.
  2. Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression.
  3. The critical role of RAGE in severe influenza infection: A target for control of inflammatory response in the disease.
  4. Deep-learning- and pharmacophore-based prediction of RAGE inhibitors.
  5. Modulating the RAGE-Induced Inflammatory Response: Peptoids as RAGE Antagonists.
  6. Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation.
  7. Receptor for Advanced Glycation End Product (RAGE) Modulates Inflammation During Feeding of the Hard Tick, Haemaphysalis longicornis in Mice.
  8. Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.
  9. [Multiple components of Mahuang Shengma Decoction on prevention and treatment of acute lung injury based on RAGE/NF-κB signaling pathway].
  10. Impact of medium cut-off membranes on S100A12 and soluble receptor for advanced glycation end products.